Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Prescription Dermatological Drugs Market Growth 2022-2028

  • LP 4926039
  • 107 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prescription Dermatological Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Prescription Dermatological Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prescription Dermatological Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prescription Dermatological Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Dermatological Drugs market, reaching US$ million by the year 2028. As for the Europe Prescription Dermatological Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Prescription Dermatological Drugs players cover Johnson & Johnson, Merck, LEO Pharma, and Mylan Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Dermatological Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Anti-acne Drugs

Anti-aging Drugs

Dermatitis Drugs

Hair Loss Drugs

Psoriasis Drugs

Skin Cancer Drugs

Melasma Drugs

Seborrhea Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Johnson & Johnson

Merck

LEO Pharma

Mylan Pharmaceuticals

Pfizer

Roche

Allergan

Bausch Health

PharmaDerm Pharmaceuticals

Allergan Inamed Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prescription Dermatological Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prescription Dermatological Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prescription Dermatological Drugs by Country/Region, 2017, 2022 & 2028

2.2 Prescription Dermatological Drugs Segment by Type

2.2.1 Anti-acne Drugs

2.2.2 Anti-aging Drugs

2.2.3 Dermatitis Drugs

2.2.4 Hair Loss Drugs

2.2.5 Psoriasis Drugs

2.2.6 Skin Cancer Drugs

2.2.7 Melasma Drugs

2.2.8 Seborrhea Drugs

2.3 Prescription Dermatological Drugs Sales by Type

2.3.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Prescription Dermatological Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prescription Dermatological Drugs Sale Price by Type (2017-2022)

2.4 Prescription Dermatological Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Prescription Dermatological Drugs Sales by Application

2.5.1 Global Prescription Dermatological Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Prescription Dermatological Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prescription Dermatological Drugs Sale Price by Application (2017-2022)

3 Global Prescription Dermatological Drugs by Company

3.1 Global Prescription Dermatological Drugs Breakdown Data by Company

3.1.1 Global Prescription Dermatological Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Company (2020-2022)

3.2 Global Prescription Dermatological Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Prescription Dermatological Drugs Revenue by Company (2020-2022)

3.2.2 Global Prescription Dermatological Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Prescription Dermatological Drugs Sale Price by Company

3.4 Key Manufacturers Prescription Dermatological Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prescription Dermatological Drugs Product Location Distribution

3.4.2 Players Prescription Dermatological Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prescription Dermatological Drugs by Geographic Region

4.1 World Historic Prescription Dermatological Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Prescription Dermatological Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prescription Dermatological Drugs Annual Revenue by Geographic Region

4.2 World Historic Prescription Dermatological Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Prescription Dermatological Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prescription Dermatological Drugs Annual Revenue by Country/Region

4.3 Americas Prescription Dermatological Drugs Sales Growth

4.4 APAC Prescription Dermatological Drugs Sales Growth

4.5 Europe Prescription Dermatological Drugs Sales Growth

4.6 Middle East & Africa Prescription Dermatological Drugs Sales Growth

5 Americas

5.1 Americas Prescription Dermatological Drugs Sales by Country

5.1.1 Americas Prescription Dermatological Drugs Sales by Country (2017-2022)

5.1.2 Americas Prescription Dermatological Drugs Revenue by Country (2017-2022)

5.2 Americas Prescription Dermatological Drugs Sales by Type

5.3 Americas Prescription Dermatological Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prescription Dermatological Drugs Sales by Region

6.1.1 APAC Prescription Dermatological Drugs Sales by Region (2017-2022)

6.1.2 APAC Prescription Dermatological Drugs Revenue by Region (2017-2022)

6.2 APAC Prescription Dermatological Drugs Sales by Type

6.3 APAC Prescription Dermatological Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prescription Dermatological Drugs by Country

7.1.1 Europe Prescription Dermatological Drugs Sales by Country (2017-2022)

7.1.2 Europe Prescription Dermatological Drugs Revenue by Country (2017-2022)

7.2 Europe Prescription Dermatological Drugs Sales by Type

7.3 Europe Prescription Dermatological Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prescription Dermatological Drugs by Country

8.1.1 Middle East & Africa Prescription Dermatological Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Prescription Dermatological Drugs Sales by Type

8.3 Middle East & Africa Prescription Dermatological Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prescription Dermatological Drugs

10.3 Manufacturing Process Analysis of Prescription Dermatological Drugs

10.4 Industry Chain Structure of Prescription Dermatological Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prescription Dermatological Drugs Distributors

11.3 Prescription Dermatological Drugs Customer

12 World Forecast Review for Prescription Dermatological Drugs by Geographic Region

12.1 Global Prescription Dermatological Drugs Market Size Forecast by Region

12.1.1 Global Prescription Dermatological Drugs Forecast by Region (2023-2028)

12.1.2 Global Prescription Dermatological Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prescription Dermatological Drugs Forecast by Type

12.7 Global Prescription Dermatological Drugs Forecast by Application

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Prescription Dermatological Drugs Product Offered

13.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Prescription Dermatological Drugs Product Offered

13.2.3 Merck Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 LEO Pharma

13.3.1 LEO Pharma Company Information

13.3.2 LEO Pharma Prescription Dermatological Drugs Product Offered

13.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 LEO Pharma Main Business Overview

13.3.5 LEO Pharma Latest Developments

13.4 Mylan Pharmaceuticals

13.4.1 Mylan Pharmaceuticals Company Information

13.4.2 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Offered

13.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Pharmaceuticals Main Business Overview

13.4.5 Mylan Pharmaceuticals Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Prescription Dermatological Drugs Product Offered

13.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Roche

13.6.1 Roche Company Information

13.6.2 Roche Prescription Dermatological Drugs Product Offered

13.6.3 Roche Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Roche Main Business Overview

13.6.5 Roche Latest Developments

13.7 Allergan

13.7.1 Allergan Company Information

13.7.2 Allergan Prescription Dermatological Drugs Product Offered

13.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Allergan Main Business Overview

13.7.5 Allergan Latest Developments

13.8 Bausch Health

13.8.1 Bausch Health Company Information

13.8.2 Bausch Health Prescription Dermatological Drugs Product Offered

13.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bausch Health Main Business Overview

13.8.5 Bausch Health Latest Developments

13.9 PharmaDerm Pharmaceuticals

13.9.1 PharmaDerm Pharmaceuticals Company Information

13.9.2 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Offered

13.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 PharmaDerm Pharmaceuticals Main Business Overview

13.9.5 PharmaDerm Pharmaceuticals Latest Developments

13.10 Allergan Inamed Corporation

13.10.1 Allergan Inamed Corporation Company Information

13.10.2 Allergan Inamed Corporation Prescription Dermatological Drugs Product Offered

13.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Allergan Inamed Corporation Main Business Overview

13.10.5 Allergan Inamed Corporation Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prescription Dermatological Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prescription Dermatological Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Anti-acne Drugs

Table 4. Major Players of Anti-aging Drugs

Table 5. Major Players of Dermatitis Drugs

Table 6. Major Players of Hair Loss Drugs

Table 7. Major Players of Psoriasis Drugs

Table 8. Major Players of Skin Cancer Drugs

Table 9. Major Players of Melasma Drugs

Table 10. Major Players of Seborrhea Drugs

Table 11. Global Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)

Table 12. Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)

Table 13. Global Prescription Dermatological Drugs Revenue by Type (2017-2022) & ($ million)

Table 14. Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2022)

Table 15. Global Prescription Dermatological Drugs Sale Price by Type (2017-2022) & (USD/Units)

Table 16. Global Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)

Table 17. Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)

Table 18. Global Prescription Dermatological Drugs Revenue by Application (2017-2022)

Table 19. Global Prescription Dermatological Drugs Revenue Market Share by Application (2017-2022)

Table 20. Global Prescription Dermatological Drugs Sale Price by Application (2017-2022) & (USD/Units)

Table 21. Global Prescription Dermatological Drugs Sales by Company (2020-2022) & (K Units)

Table 22. Global Prescription Dermatological Drugs Sales Market Share by Company (2020-2022)

Table 23. Global Prescription Dermatological Drugs Revenue by Company (2020-2022) ($ Millions)

Table 24. Global Prescription Dermatological Drugs Revenue Market Share by Company (2020-2022)

Table 25. Global Prescription Dermatological Drugs Sale Price by Company (2020-2022) & (USD/Units)

Table 26. Key Manufacturers Prescription Dermatological Drugs Producing Area Distribution and Sales Area

Table 27. Players Prescription Dermatological Drugs Products Offered

Table 28. Prescription Dermatological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Prescription Dermatological Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 32. Global Prescription Dermatological Drugs Sales Market Share Geographic Region (2017-2022)

Table 33. Global Prescription Dermatological Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 34. Global Prescription Dermatological Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 35. Global Prescription Dermatological Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 36. Global Prescription Dermatological Drugs Sales Market Share by Country/Region (2017-2022)

Table 37. Global Prescription Dermatological Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 38. Global Prescription Dermatological Drugs Revenue Market Share by Country/Region (2017-2022)

Table 39. Americas Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)

Table 40. Americas Prescription Dermatological Drugs Sales Market Share by Country (2017-2022)

Table 41. Americas Prescription Dermatological Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 42. Americas Prescription Dermatological Drugs Revenue Market Share by Country (2017-2022)

Table 43. Americas Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)

Table 44. Americas Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)

Table 45. Americas Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)

Table 46. Americas Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)

Table 47. APAC Prescription Dermatological Drugs Sales by Region (2017-2022) & (K Units)

Table 48. APAC Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)

Table 49. APAC Prescription Dermatological Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 50. APAC Prescription Dermatological Drugs Revenue Market Share by Region (2017-2022)

Table 51. APAC Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)

Table 52. APAC Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)

Table 53. APAC Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)

Table 54. APAC Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)

Table 55. Europe Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)

Table 56. Europe Prescription Dermatological Drugs Sales Market Share by Country (2017-2022)

Table 57. Europe Prescription Dermatological Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 58. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2017-2022)

Table 59. Europe Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)

Table 60. Europe Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)

Table 61. Europe Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)

Table 62. Europe Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)

Table 63. Middle East & Africa Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)

Table 64. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country (2017-2022)

Table 65. Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 66. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country (2017-2022)

Table 67. Middle East & Africa Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)

Table 68. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)

Table 69. Middle East & Africa Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)

Table 70. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)

Table 71. Key Market Drivers & Growth Opportunities of Prescription Dermatological Drugs

Table 72. Key Market Challenges & Risks of Prescription Dermatological Drugs

Table 73. Key Industry Trends of Prescription Dermatological Drugs

Table 74. Prescription Dermatological Drugs Raw Material

Table 75. Key Suppliers of Raw Materials

Table 76. Prescription Dermatological Drugs Distributors List

Table 77. Prescription Dermatological Drugs Customer List

Table 78. Global Prescription Dermatological Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. Global Prescription Dermatological Drugs Sales Market Forecast by Region

Table 80. Global Prescription Dermatological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 82. Americas Prescription Dermatological Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Americas Prescription Dermatological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. APAC Prescription Dermatological Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 85. APAC Prescription Dermatological Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 86. Europe Prescription Dermatological Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Europe Prescription Dermatological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Middle East & Africa Prescription Dermatological Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 89. Middle East & Africa Prescription Dermatological Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Global Prescription Dermatological Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 91. Global Prescription Dermatological Drugs Sales Market Share Forecast by Type (2023-2028)

Table 92. Global Prescription Dermatological Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 93. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 94. Global Prescription Dermatological Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 95. Global Prescription Dermatological Drugs Sales Market Share Forecast by Application (2023-2028)

Table 96. Global Prescription Dermatological Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 97. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 98. Johnson & Johnson Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Johnson & Johnson Prescription Dermatological Drugs Product Offered

Table 100. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 101. Johnson & Johnson Main Business

Table 102. Johnson & Johnson Latest Developments

Table 103. Merck Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck Prescription Dermatological Drugs Product Offered

Table 105. Merck Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 106. Merck Main Business

Table 107. Merck Latest Developments

Table 108. LEO Pharma Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. LEO Pharma Prescription Dermatological Drugs Product Offered

Table 110. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 111. LEO Pharma Main Business

Table 112. LEO Pharma Latest Developments

Table 113. Mylan Pharmaceuticals Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Mylan Pharmaceuticals Prescription Dermatological Drugs Product Offered

Table 115. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 116. Mylan Pharmaceuticals Main Business

Table 117. Mylan Pharmaceuticals Latest Developments

Table 118. Pfizer Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Pfizer Prescription Dermatological Drugs Product Offered

Table 120. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 121. Pfizer Main Business

Table 122. Pfizer Latest Developments

Table 123. Roche Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Roche Prescription Dermatological Drugs Product Offered

Table 125. Roche Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 126. Roche Main Business

Table 127. Roche Latest Developments

Table 128. Allergan Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Allergan Prescription Dermatological Drugs Product Offered

Table 130. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 131. Allergan Main Business

Table 132. Allergan Latest Developments

Table 133. Bausch Health Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. Bausch Health Prescription Dermatological Drugs Product Offered

Table 135. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 136. Bausch Health Main Business

Table 137. Bausch Health Latest Developments

Table 138. PharmaDerm Pharmaceuticals Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Offered

Table 140. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 141. PharmaDerm Pharmaceuticals Main Business

Table 142. PharmaDerm Pharmaceuticals Latest Developments

Table 143. Allergan Inamed Corporation Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Allergan Inamed Corporation Prescription Dermatological Drugs Product Offered

Table 145. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2020-2022)

Table 146. Allergan Inamed Corporation Main Business

Table 147. Allergan Inamed Corporation Latest Developments

List of Figures

Figure 1. Picture of Prescription Dermatological Drugs

Figure 2. Prescription Dermatological Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prescription Dermatological Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prescription Dermatological Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prescription Dermatological Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Anti-acne Drugs

Figure 10. Product Picture of Anti-aging Drugs

Figure 11. Product Picture of Dermatitis Drugs

Figure 12. Product Picture of Hair Loss Drugs

Figure 13. Product Picture of Psoriasis Drugs

Figure 14. Product Picture of Skin Cancer Drugs

Figure 15. Product Picture of Melasma Drugs

Figure 16. Product Picture of Seborrhea Drugs

Figure 17. Global Prescription Dermatological Drugs Sales Market Share by Type in 2021

Figure 18. Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2022)

Figure 19. Prescription Dermatological Drugs Consumed in Hospital Pharmacies

Figure 20. Global Prescription Dermatological Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 21. Prescription Dermatological Drugs Consumed in Retail Pharmacies

Figure 22. Global Prescription Dermatological Drugs Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 23. Prescription Dermatological Drugs Consumed in Online Pharmacies

Figure 24. Global Prescription Dermatological Drugs Market: Online Pharmacies (2017-2022) & (K Units)

Figure 25. Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)

Figure 26. Global Prescription Dermatological Drugs Revenue Market Share by Application in 2021

Figure 27. Prescription Dermatological Drugs Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Prescription Dermatological Drugs Revenue Market Share by Company in 2021

Figure 29. Global Prescription Dermatological Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Prescription Dermatological Drugs Revenue Market Share by Geographic Region in 2021

Figure 31. Global Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)

Figure 32. Global Prescription Dermatological Drugs Revenue Market Share by Country/Region in 2021

Figure 33. Americas Prescription Dermatological Drugs Sales 2017-2022 (K Units)

Figure 34. Americas Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)

Figure 35. APAC Prescription Dermatological Drugs Sales 2017-2022 (K Units)

Figure 36. APAC Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Europe Prescription Dermatological Drugs Sales 2017-2022 (K Units)

Figure 38. Europe Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Prescription Dermatological Drugs Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Prescription Dermatological Drugs Revenue 2017-2022 ($ Millions)

Figure 41. Americas Prescription Dermatological Drugs Sales Market Share by Country in 2021

Figure 42. Americas Prescription Dermatological Drugs Revenue Market Share by Country in 2021

Figure 43. United States Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Prescription Dermatological Drugs Sales Market Share by Region in 2021

Figure 48. APAC Prescription Dermatological Drugs Revenue Market Share by Regions in 2021

Figure 49. China Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2021

Figure 56. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2021

Figure 57. Germany Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country in 2021

Figure 64. Egypt Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Prescription Dermatological Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Prescription Dermatological Drugs in 2021

Figure 70. Manufacturing Process Analysis of Prescription Dermatological Drugs

Figure 71. Industry Chain Structure of Prescription Dermatological Drugs

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390